For nearly 35 years, IRIS, Le Groupe Visuel, has distinguished itself by its commitment to offering high-quality products and services in the field of vision care. With a network of stores spanning several provinces, IRIS has never stopped innovating to improve the experience and clinical outcomes of its patients. Since 2022, we have been taking another decisive step forward by integrating artificial intelligence (AI) into eye disease detection, thanks to IRIS-ai.
The rise of technology in the service of visual health
Technology has always played a key role in the evolution of eye care. From traditional examinations to the introduction of advanced diagnostic techniques such as retinal imaging, IRIS has continually adapted its practices to offer increasingly precise care. However, with the advent of artificial intelligence, a true revolution is underway.
IRIS-ai, our artificial intelligence solution, enables early detection of various ocular pathologies, such as age-related macular degeneration (AMD), diabetic retinopathy and glaucoma. These diseases, often asymptomatic in their early stages, can lead to permanent vision loss if not diagnosed and treated in time. IRIS-ai acts as a clinical support tool, helping optometrists spot subtle signs of these diseases that might otherwise go unnoticed.
IRIS-ai's impact on eye care
Artificial intelligence enables in-depth analysis of retinal images and clinical data with speed and accuracy. IRIS-ai is constantly evolving, perfecting its algorithms as it processes additional data. This improves the rate of early detection, giving patients a better chance of treatment and preserving their vision.
What sets IRIS-ai apart is its ability to collaborate with our vision care professionals. AI does not replace humans but complements them by automating repetitive tasks while leaving room for human expertise to interpret results and propose personalized treatments.
An enhanced patient experience
For IRIS patients, this innovation means greater peace of mind. Eye examinations become more precise and tailored to their specific needs. Moreover, patients benefit from clear and rapid communication of their results, with detailed explanations of their eye health status and professional recommendations.
The integration of IRIS-ai is not limited to disease detection. It also makes it possible to monitor treatment progress in real-time, offering patients personalized follow-up throughout their care pathway. This reinforces IRIS' commitment to providing quality care while taking a proactive approach to prevention.
Looking to the future with IRIS
At IRIS, we believe that the future of eye care lies in the combination of cutting-edge technology and human expertise. IRIS-ai embodies this balance, empowering our professionals to deliver more precise care while making eye examinations more accessible and personalized.
With IRIS-ai, we are taking a major step forward in the prevention and management of eye diseases while remaining at the forefront of innovation in the vision care industry.
